Founded in 1996, APP Pharmaceuticals is a leading manufacturer of multi-source and branded injectable pharmaceutical products for acute medical care both in patient and ambulatory settings. Through continuous expansion of its’ broad portfolio of products covering a wide array of therapeutic categories, our products provide ongoing affordable healthcare helping millions of people in the United States and Canada fight critical illnesses.

Headquartered in Schaumburg, Illinois, our 1,400 employees are united in their commitment to operations excellence in the ultimate effort to provide products that elevate patient care. APP, which was acquired by Fresenius Kabi Pharmaceuticals Holding, Inc. in September 2008, has offices in Canada and manufacturing operations in Illinois, New York and Puerto Rico. Fresenius Kabi Pharmaceuticals Holding trades on The Nasdaq Global Market under the symbol APCVZ.